← Open Payments lookup

ANGELA SOYOMBO: Open Payments

NPI 1326584665 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$489 in 23 payments from 10 companies in 2025. Trend: 2023 $343 · 2024 $196 · 2025 $489

Food & beverage: $489
CompanyPaymentsAmount
ABBVIE INC.5$99
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$84
Madrigal Pharmaceuticals5$80
Takeda Pharmaceuticals U.S.A., Inc.3$70
Baxter Healthcare1$43
Merck Sharp & Dohme LLC1$26
Pacira Pharmaceuticals Incorporated1$26
Mallinckrodt Hospital Products Inc.1$26
Caris MPI, Inc.1$19
Intercept Pharmaceuticals, Inc.1$17

Products named: XIFAXAN, REZDIFFRA, LIVTENCITY, PERCLOT, TEFLARO, ZERBAXA, Exparel, TERLIVAZ.

Industry payments across TX — which companies pay providers there.